Global Sarcopenia Treatment Market to Reach $4.72 Billion by 2029, Growing at 6% CAGR

Which drivers are expected to have the greatest impact on the over the sarcopenia treatment market's growth?
The sarcopenia treatment market is expected to gain traction as malnutrition increases globally. Malnutrition includes deficiencies, excesses, and an imbalance of energy and nutrients a person consumes, encompassing undernutrition, overweight issues, obesity, and diet-related noncommunicable diseases. Treatments for sarcopenia are beneficial in managing malnutrition and sarcopenia that typically coexist in the elderly population. These treatments, including nutritional therapy and exercise, are geared towards enhancing muscle mass, strength, and overall nutritional health. For example, a report by the World Health Organization, a United Nations organization based in Switzerland, revealed in December 2023 that malnutrition is still a substantial global health problem. The report indicated that roughly 462 million people were underweight and 149 million children under the age of five experienced stunting in 2022. It is this increasing malnutrition that's fuelling the sarcopenia treatment market's growth.

Get Your Sarcopenia Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report

What is the future CAGR of the sarcopenia treatment market, and how will it impact industry expansion?
In recent times, the market size of sarcopenia treatment has experienced substantial growth. The growth will progress from $3.52 billion in 2024 to an estimated $3.73 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.1%. Factors that contributed to the growth during the historical period include the aging population, increased awareness and diagnosis, altered lifestyles, public health efforts, and regulatory approvals.

The market for sarcopenia treatment is projected to experience robust expansion in the coming years, with an estimated value of $4.72 billion in 2029 and a compound annual growth rate (CAGR) of 6.0%. This anticipated growth over the forecast period is likely due to factors such as personalised medicine, nutritional interventions, digital health platforms, patient awareness and empowerment, and worldwide health programmes. The forecast period is also expected to witness significant trends including bespoke therapies, the advent of new drug groups, integration of digital health, cooperative study initiatives, and research and development.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13926&type=smp

What are the most significant trends transforming the sarcopenia treatment market today?
Significant corporations in the sector of sarcopenia therapy are devoting their resources towards the development of innovative advanced clinical options. This is part of an endeavor to establish more effective treatment methods. Clinical studies, carried out on humans, aim to assess the potential efficacy, safety, and outcome of a medical procedure or treatment. Biophytis, a biotech organization from France, for instance, was granted permission by the FDA in September 2023 to start the SARA-31 Phase 3 study for sarcopenia. The main objective of this study is to review the safety and effectiveness of Sarconeos (BIO101), in treating sarcopenia patients at the risk of motor disability. This research is a breakthrough in technological and pharmaceutical treatment techniques, addressing the dire need for efficacious and safe treatments for patients suffering from severe sarcopenia. This FDA-approved Phase 3 study is unprecedented in the field of sarcopenia. Approximately 900 sarcopenia patients over the age of 65, with decreased walking pace and handgrip strength, are to be included in this study. Major mobility disability (MMD), hand grip strength, walking speed, and self-reported quality of life are all variables to be evaluated as primary endpoints.

Which key market segments comprise the sarcopenia treatment market and drive its revenue growth?
The sarcopenia treatment market covered in this report is segmented -

1) By Treatment Type: Protein Supplements, Vitamin B12 Supplements, Vitamin D And Calcium Supplements, Other Treatment Types
2) By Type: Primary Sarcopenia, Secondary Sarcopenia
3) By Route Of Administration: Oral, Parenteral, Enteral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:
1) By Protein Supplements: Whey Protein, Casein Protein, Soy Protein, Plant-Based Protein
2) By Vitamin B12 Supplements: Cyanocobalamin, Methylcobalamin
3) By Vitamin D And Calcium Supplements: Vitamin D2, Vitamin D3, Calcium Carbonate, Calcium Citrate
4) By Other Treatment Types: Exercise Programs, Hormone Replacement Therapy, Other Nutritional Interventions

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13926

North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the sarcopenia treatment market?
Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13926&type=smp

What Is Covered In The Sarcopenia Treatment Global Market Report?

•Market Size Forecast: Examine the sarcopenia treatment market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the sarcopenia treatment market for a structured understanding.
•Key Players Overview: Analyze major players in the sarcopenia treatment market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the sarcopenia treatment market.
•Segment Contributions: Evaluate how different segments drive overall growth in the sarcopenia treatment market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the sarcopenia treatment market.
•Industry Challenges: Identify potential risks and obstacles affecting the sarcopenia treatment market.
•Competitive Landscape: Review strategic developments in the sarcopenia treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.